Published on 18 March 2025
Description:
PMLiVE’s Top Pharma List is live!; Omnichannel – breaking down the barriers; Rare diseases – improving patient access
Categories:
Pharmaceutical Market EuropePreview:
30 articles from this collection:
PME March 2025
2 PME
3 Comment
4 Communique Awards 2025
5 Contents
6-7 News
Roche and Ascidian agree to $1.8bn neurological disease partnership
8-9 News
Researchers identify new major cause of inflammatory bowel disease
10-11 Dermatology News
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
12 DARWIN'S MEDICINE - Innovation’s one real law
The evolutionary lessons for Bayer’s management restructure
13 MIKE DIXON - The importance of the human touch in today’s AI world
Collecting the right data in the right way for the right reasons
14 INNOVATIVE IMPACT BLOG - THE AI ADVANTAGE: SEVEN STEPS TO AUGMENTED PHARMA BRAND PLANNING
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
15 HEALTHCARE COMMUNICATIONS - IS CRITICAL THINKING AT RISK?
16-17 RARE DISEASES - Defying the odds: speeding patient access to life-changing treatments
Across almost every sector, brands are multiplying their investment in creativity
18 TL ICON - Harnessing AI and big data in clinical research
What value does your strategic planning add?
19 WOMEN IN PHARMA
20 TL MEDSCAPE MEDICAL AFFAIRS - Breaking boundaries In medical affairs: how measurable outcomes
21-23 PMLIVE’S TOP PHARMA LIST - PMLiVE’s Top Pharma list – results and predictions
Picking your omnichannel direction requires a disciplined, scientific approach
24-25 ALS DISEASE - ALS – innovative developments and investigational treatments
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
26 SOCIETY FOR ENDOCRINOLOGY CONFERENCE - The Society for Endocrinology conference
27 TL IQVIA - Omnichannel: from theory to successful implementation
28-30 OMNICHANNEL ENGAGEMENT - Breaking down the barriers
31 TL KANGA - From zero to hero: is zero-party data your new best friend for omnichannel
32 FlyPharma Amsterdam 2025
33 TL VEEVA - Mastering KAM excellence: achieving meaningful growth from top accounts
34-35 LIFE SCIENCES – Life sciences in Europe – the top 20 global cities
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
36 Appointments
37 Appointments
38 Appointments
39 HEALTHCARE COMMS
40 PharmaRole
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services